Owner Vertex Pharmaceuticals Incorporated

Inventors Van drie, John; Pitlik, Janos; Courtney, Lawrence; Perni, Robert; Farmer, Luc

Agent Cullen & Co

Pub. Number AU-B-2002320447

PCT Number PCT/US02/22027

PCT Pub. Number WO2003/006490

Priority 60/304,615 11.07.01 US; 60/322,714 17.09.01 US

Filing date 11 July 2002

Wipo publication date 29 January 2003

Acceptance publication date 19 April 2007

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/13 (2006.01) - Amines, e.g. amantadine

A61K 31/7052 (2006.01)

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 5/103 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/107 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/11 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/117 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence